Emerging treatments for bullous pemphigoid
- Authors: Pedro Miguel Garrido, Catarina Soares Queirós, Ana Rita Travassos, João Borges-Costa, Paulo Filipe
- Publication Year: 2021
- Journal: Journal of Dermatological Treatment
- Link: https://doi.org/10.1080/09546634.2020.1782325
ABSTRACT Bullous pemphigoid (BP) is the most common autoimmune blistering disease. It is characterized by an immune response against the hemidesmosomal anchoring proteins BP180 and BP230. BP mainly affects elderly patients, with an increasing incidence over the past two decades. High potency topical and/or systemic corticosteroids as well as immunosuppressants are the current mainstay of […]
Read More